학술논문
Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials
Document Type
Article
Author
Source
In The Lancet Diabetes & Endocrinology November 2020 8(11):880-893
Subject
Language
ISSN
2213-8587